Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Motivational interviews to help maintain abstinence after alcohol withdrawal

Official title: IMMANENCE - Intérêt d'un Suivi Sous Forme d'Entretiens Motivationnels spécifiques Post Hospitalisation Sur le Maintien de l'AbstiNENCE Durant l'année Suivant le Sevrage en Alcool

Run by University Hospital, Montpellier · NCT06618755 · Data updated 2026-11-12

This study tests if using motivational interviews as extra support can help adults who have just gone through alcohol withdrawal stay sober longer compared to regular care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment104 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier)
StatusRecruiting
StartedDecember 18, 2024
Main results expectedJanuary 13, 2028
Study endsJanuary 13, 2028
Registry record updatedJune 18, 2026
Trial IDNCT06618755 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with alcohol use disorders who are undergoing inpatient withdrawal and aim for complete abstinence.

Probably not a fit

Patients who do not understand French or have serious cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study evaluates the effectiveness of reinforced inpatient aftercare, specifically motivational interviewing, compared to usual care for adults with alcohol use disorders following hospital withdrawal. The focus is on increasing the percentage of days of abstinence and reducing relapse rates during the first year post-withdrawal. Participants will receive regular assessments to monitor their abstinence and motivation levels. The study aims to address the high risk of relapse during the consolidation phase after withdrawal, utilizing motivational interviewing as a supportive tool.

Why it matters

Potential benefit: If successful, this approach could significantly improve long-term abstinence rates for individuals recovering from alcohol use disorders.

How similar studies have gone: Previous studies have shown that motivational interviewing can be effective in supporting behavior change, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months).
* Being treated for withdrawal in hospital.
* With a goal of complete abstinence.
* With a means of communication (telephone).

Exclusion Criteria:

* Lack of understanding (written and spoken) of the French language.
* Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction.
* Eviction from the department, discharge against medical advice during hospitalisation for withdrawal.
* Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up.
* Serious decompensated somatic pathology.
* Non-membership or non-beneficiaries of a national health insurance scheme.
* Person protected by law, under guardianship or curatorship.
* Not having signed free and informed consent to participate in the research.
* Simultaneous participation in another clinical trial.

Where it's running

  • Thomas RISDORFER DE ISSDENTZI
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.